|

Placebo Cap Clinical Trials

3 actively recruiting trials

Pipeline

Phase 2: 3

Top Sponsors

  • China Medical University Hospital3

Indications

  • Depression3
  • Major Depressive Disorder2
  • Bipolar I Disorder1

Other3 trials

NMDA Modulation in Antidepressant Nonresponders With Major Depressive Disorder
Phase 2
NMDA Modulation in Major Depressive Disorder
Phase 2
NMDA Receptor Modulation for the Treatment of Bipolar I Disorder
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.